Scarica l'app Stockscreener
0.4349
0.53%
-0.0023
Dopo l'orario di chiusura:
.41
-0.0249
-5.73%
Precedente Chiudi:
$0.4372
Aprire:
$0.41
Volume 24 ore:
140.49K
Relative Volume:
1.43
Capitalizzazione di mercato:
$3.03M
Reddito:
-
Utile/perdita netta:
$-736.70K
Rapporto P/E:
-43.49
EPS:
-0.01
Flusso di cassa netto:
$-4.14M
1 W Prestazione:
+8.62%
1M Prestazione:
-26.91%
6M Prestazione:
-50.58%
1 anno Prestazione:
-54.70%
Intervallo 1D:
$0.41
$0.4369
Intervallo di 1 settimana:
$0.394
$0.45
Portata 52W:
$0.382
$1.41
Xortx Therapeutics Inc Stock (XRTX) Company Profile
Nome
Xortx Therapeutics Inc
Settore
Industria
Telefono
-
Indirizzo
-
Compare XRTX vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XRTX
Xortx Therapeutics Inc
|
0.4349 | 3.04M | 0 | -736.70K | -4.14M | -0.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Xortx Therapeutics Inc Borsa (XRTX) Ultime notizie
Will XORTX Therapeutics Inc. outperform during market ralliesWeekly Stock Report & Growth Oriented Trade Recommendations - mfd.ru
Trading Action: What is XORTX Therapeutics Incs TAM Total Addressable MarketMarket Performance Recap & Verified Technical Signals - baoquankhu1.vn
XORTX Therapeutics Brief: Provided Overnight Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems - marketscreener.com
XORTX Extends Closing Of Renal Anti-Fibrotic Therapeutic Program Acquisition; Stock Soars - Nasdaq
XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems - markets.businessinsider.com
Kidney drug deal: XORTX gets more time to close Vectus buy - Stock Titan
XORTX (NASDAQ: XRTX) extends VB4-P5 kidney fibrosis deal deadline - Stock Titan
Investor Mood: Why is OSBC stock going upRate Cut & Real-Time Price Movement Reports - baoquankhu1.vn
Travel Stocks: Whats the RSI of XORTX Therapeutics Inc stock2025 Retail Activity & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
XORTX Therapeutics Inc. (XRTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
EPS Watch: Can XORTX Therapeutics Inc continue delivering strong returns - baoquankhu1.vn
Is XORTX Therapeutics Inc. a speculative investment2025 Market WrapUp & Weekly Consistent Profit Watchlists - mfd.ru
Does XORTX Therapeutics Inc. meet Warren Buffett’s criteriaWeekly Trend Report & Short-Term Trading Opportunity Alerts - mfd.ru
Earnings Miss: What is the target price for XORTX Therapeutics Inc stockInflation Watch & Proven Capital Preservation Tips - baoquankhu1.vn
Treasury Yields: Does XORTX Therapeutics Inc meet Warren Buffetts criteriaJuly 2025 PostEarnings & Weekly Breakout Watchlists - baoquankhu1.vn
Market Fear: What is XORTX Therapeutics Incs TAM Total Addressable MarketJuly 2025 Momentum & AI Optimized Trade Strategies - baoquankhu1.vn
XORTX leans into genetic breakthroughs in gout as it reshapes board and advances oxypurinol - MSN
Dividend Watch: Is XORTX Therapeutics Inc vulnerable to short sellers2025 Major Catalysts & Technical Buy Zone Confirmations - baoquankhu1.vn
Sentiment Recap: How XORTX Therapeutics Inc stock performs after earningsWeekly Trade Review & Reliable Momentum Entry Alerts - Bộ Nội Vụ
Is XORTX Therapeutics Inc. stock positioned well for digital economyOil Prices & Weekly Setup with ROI Potential - Улправда
Revenue per share of XORTX Therapeutics Inc. – NASDAQ:XRTX - TradingView — Track All Markets
Why XORTX Therapeutics Inc. stock remains resilientJuly 2025 Intraday Action & Trade Opportunity Analysis Reports - Улправда
Is XORTX Therapeutics Inc. (ANUA) stock a buy before earnings resultsQuarterly Trade Review & Weekly Top Stock Performers List - ulpravda.ru
Will XORTX Therapeutics Inc. stock attract more institutional investors2025 Risk Factors & Long Hold Capital Preservation Tips - ulpravda.ru
Contact | Statesman-ExaminerXORTX Therapeutics Inc.Common Stock (Nasdaq:XRTX) Stock Quote - FinancialContent
XORTX Therapeutics : Investor Presentation - MarketScreener
Will XORTX Therapeutics Inc. stock beat EPS estimatesStock Split Announcements & High Profit Portfolio Growth - Улправда
Published on: 2026-01-07 21:30:14 - Улправда
XORTX highlights new gout genetics research, reshapes board and clarifies financing as Vectus deal nears closing - MSN
XORTX Leans Into Genetic Breakthroughs in Gout as It Reshapes Board and Advances Oxypurinol - TipRanks
Huge gout genetics study highlights target in kidney disease research - Stock Titan
XORTX Announces USD $3 Million Offering - 富途牛牛
Multi Factor Analysis Ranks Jaihind Synthetics Limited as Strong BuyInsider Selling Patterns & Lower Drawdowns With Smart Position Sizing - bollywoodhelpline.com
Order Book Volume Tilts Bullish on Adani Wilmar LimitedCurrency Fluctuation Impact & Breakout Stock Alerts - bollywoodhelpline.com
Chart Analysts Warn of Resistance Near Glance Finance Limited PriceCapital Gains Strategies & Small Capital Trading Plans - bollywoodhelpline.com
Fibonacci Levels Suggest Recovery for Johnson Pharmacare LimitedMomentum Trading Signals & Analysts Are Raving About These Shares - bollywoodhelpline.com
Global Longlife Hospital and Research Limited (543520) Sees Unusual Trading VolumeFinancial Sector Performance & Small Entry Cost Trading - bollywoodhelpline.com
Can Fabino Life Sciences Limited Bounce Back From Weekly LowEx-Dividend Date Alerts & Outstanding Investment Returns - bollywoodhelpline.com
What drives XORTX Therapeutics Inc stock priceEconomic Data Impact & Free Stock Market Mentorship Programs - earlytimes.in
Aug Decliners: Why XORTX Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Sector Moves & Fast Gaining Stock Reports - ulpravda.ru
How XORTX Therapeutics Inc. stock reacts to inflationary pressures2025 Fundamental Recap & Free Real-Time Market Sentiment Alerts - Улправда
Why XORTX Therapeutics Inc. (ANUA) stock could be top winnerJuly 2025 Snapshot & Verified Entry Point Signals - Улправда
Why XORTX Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Pullbacks & Real-Time Market Sentiment Reports - Улправда
Growth Value: Is XORTX Therapeutics Inc. stock positioned well for digital economyJuly 2025 Snapshot & Low Drawdown Trading Techniques - Улправда
Will XORTX Therapeutics Inc. stock attract ESG investorsCEO Change & Daily Technical Forecast Reports - Улправда
What technical charts say about XORTX Therapeutics Inc. stockStock Surge & Accurate Intraday Trading Signals - Улправда
Xortx Therapeutics Inc Azioni (XRTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):